Stock IdeasStrong Buy Stocks
Strong Buy Stocks from Top Wall Street Analysts
Latest stocks with a Strong Buy rating from the top performing 25% of analysts tracked by WallStreetZen

Analyst / FirmCompanyPriceRatingPrice TargetUpside/DownsideDate
Etzer Darout
Barclays
Top 2%
99
Oruka Therapeutics IncORKA
$40.00Strong Buy$50.00+25.00%
16 hours ago
Analyst Ranking
Top 2%
#92 out of 5217 analysts
Average Return
+34.87%
Win Rate
52%85 out of 163
Risk vs Reward
Poor
Good

Analyst Color

Barclays's Etzer Darout raised their price target on Oruka Therapeutics (NASDAQ: ORKA) by 4.2% from $48 to $50 on 2026/03/13. The analyst maintained their Strong Buy rating on the stock.

Oruka Therapeutics reported its Q4 and FY 2025 earnings.

Raising their price target, Darout looked ahead and said they are positive on the name ahead of Phase 2 data next quarter, as ORKA-002 development continues to progress with a "clear benchmark" from Skyrizi."

Philippe Houchois
Jefferies
Top 19%
82
Tesla IncTSLA
$800.00Strong Buy$850.00+6.25%
a day ago

Upgrade to Premium to View More

Strong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts

Already have access to Premium? Sign In
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.